ARCHIVES

Bristol Stock Drops Amid New Setbacks, Deepening Firm’s Decline In Oncology

This article is from The Cancer Letter archive.

Vol. 28 No. 14 | April 5, 2002

Download PDF Visit The Full Archive

Related Articles

NCCS Names 7 To Board; FDA Approves Warning Labels for Hormone Therapy

January 17, 2003

NCI’s Future Depends On Recruiting Youth to Careers in Science, NCI Director Says at His Swearing-In Ceremony.

October 20, 2006

In Brief: James Cancer Hospial Recieves $20M Donation

January 22, 1999

Under Ultimatum, NIH Databases Remove “Misconduct” Tags From Papers By Fisher

February 24, 1995

Women Radiated For Wilms’ At Risk For Complications In Pregnancy, Study Finds

May 31, 2002

Mayo Clinic Develops New Jaw Reconstruction Method

August 25, 2006